Expectations
- Organism
- Homo sapiens
- Assay
- bulk RNA-seq
- Specimen/source
- patient tissue or biopsy
- Controls
- matched normal, adjacent normal, paired normal, healthy tissue control, or otherwise normal tissue control
Siftome Phase 3L
GSE123762Both case and control groups are present in the proposed grouping.
Each contrast group has at least 2 samples.
Processed data is marked available in the GEO index.
All samples are assigned to a case or control group.
No dataset warnings are present.
Metadata quality is high enough to support downstream handoff.
No readiness blockers detected.
Siftome proposed case and control labels, but no reviewer confirmation is stored yet.
Open the sample grouping CSV and confirm group labels before analysis.Both groups meet the minimum of 2 samples.
Confirm whether the cohort is large enough for the intended statistical analysis.Processed data availability is marked true in the GEO index.
Verify that downloaded processed files contain usable count or expression identifiers.No review-needed or unassigned samples are present in the proposed grouping.
Still scan the grouping table for biology-specific ambiguity.No hard-excluded samples were detected by the current rules.
Record any manual exclusions in the downstream analysis notes.The dataset and sample accessions can be linked back to GEO.
Keep GEO dataset and sample links with exported metadata.Proceed only after the analyst confirms grouping, exclusions, and source files.
No expert-review triggers were detected by Siftome.
No ranking warnings are active.
No active review decisions affect this ranking.
No active manual corrections are applied to this dataset.
Homo sapiens
dataset_accession: GSE123762 organism: Homo sapiens dataset_title: The Androgen Receptor is a Tumor Suppressor in Estrogen Receptor Positive Breast Cancer [Normal and tumor patient-derived explant RNA-seq]
bulk RNA-seq
assay_type: bulk RNA-seq experiment_types: Expression profiling by high throughput sequencing platforms: GPL16791 Illumina HiSeq 2500 (Homo sapiens) dataset_title: The Androgen Receptor is a Tumor Suppressor in Estrogen Receptor Positive Breast Cancer [Normal and tumor patient-derived explant RNA-seq]
Tumor vs unmatched normal
dataset_title: The Androgen Receptor is a Tumor Suppressor in Estrogen Receptor Positive Breast Cancer [Normal and tumor patient-derived explant RNA-seq] experiment_types: Expression profiling by high throughput sequencing sample_context: GSM3510975: source_name=ER+ invasive breast cancer_E2; characteristics=patient id: 1; tissue type: ER+ invasive breast cancer; treatment: E2 GSM3510976: source_name=ER+ invasive breast cancer_E2; characteristics=patient id: 2; tissue type: ER+ invasive breast cancer; treatment: E2 GSM3510977: source_name=ER+ invasive breast cancer_E2; characteristics=patient id: 3; tissue type: ER+ invasive breast cancer; treatment: E2 GSM3510978: source_name=ER+ invasive breast cancer_E2; characteristics=patient id: 4; tissue type: ER+ invasive breast cancer; treatment: E2 GSM3510979: source_name=ER+ invasive breast cancer_E2; characteristics=patient id: 5; tissue type [Correction source preview truncated.]
Tissue
dataset_title: The Androgen Receptor is a Tumor Suppressor in Estrogen Receptor Positive Breast Cancer [Normal and tumor patient-derived explant RNA-seq] sample_context: GSM3510975: source_name=ER+ invasive breast cancer_E2; characteristics=patient id: 1; tissue type: ER+ invasive breast cancer; treatment: E2 GSM3510976: source_name=ER+ invasive breast cancer_E2; characteristics=patient id: 2; tissue type: ER+ invasive breast cancer; treatment: E2 GSM3510977: source_name=ER+ invasive breast cancer_E2; characteristics=patient id: 3; tissue type: ER+ invasive breast cancer; treatment: E2 GSM3510978: source_name=ER+ invasive breast cancer_E2; characteristics=patient id: 4; tissue type: ER+ invasive breast cancer; treatment: E2 GSM3510979: source_name=ER+ invasive breast cancer_E2; characteristics=patient id: 5; tissue type: ER+ invasive breast cancer; treatment: E2 GSM3510980: source_name=E [Correction source preview truncated.]
breast cancer
dataset_title: The Androgen Receptor is a Tumor Suppressor in Estrogen Receptor Positive Breast Cancer [Normal and tumor patient-derived explant RNA-seq] sample_context: GSM3510975: source_name=ER+ invasive breast cancer_E2; characteristics=patient id: 1; tissue type: ER+ invasive breast cancer; treatment: E2 GSM3510976: source_name=ER+ invasive breast cancer_E2; characteristics=patient id: 2; tissue type: ER+ invasive breast cancer; treatment: E2 GSM3510977: source_name=ER+ invasive breast cancer_E2; characteristics=patient id: 3; tissue type: ER+ invasive breast cancer; treatment: E2 GSM3510978: source_name=ER+ invasive breast cancer_E2; characteristics=patient id: 4; tissue type: ER+ invasive breast cancer; treatment: E2 GSM3510979: source_name=ER+ invasive breast cancer_E2; characteristics=patient id: 5; tissue type: ER+ invasive breast cancer; treatment: E2 GSM3510980: source_name=E [Correction source preview truncated.]
Eligible for Patient tissue tumor-vs-normal as Not suitable
dataset_accession: GSE123762 dataset_title: The Androgen Receptor is a Tumor Suppressor in Estrogen Receptor Positive Breast Cancer [Normal and tumor patient-derived explant RNA-seq] organism: Homo sapiens assay_type: bulk RNA-seq sample_context: GSM3510975: source_name=ER+ invasive breast cancer_E2; characteristics=patient id: 1; tissue type: ER+ invasive breast cancer; treatment: E2 GSM3510976: source_name=ER+ invasive breast cancer_E2; characteristics=patient id: 2; tissue type: ER+ invasive breast cancer; treatment: E2 GSM3510977: source_name=ER+ invasive breast cancer_E2; characteristics=patient id: 3; tissue type: ER+ invasive breast cancer; treatment: E2 GSM3510978: source_name=ER+ invasive breast cancer_E2; characteristics=patient id: 4; tissue type: ER+ invasive breast cancer; treatment: E2 GSM3510979: source_name=ER+ invasive breast cancer_E2; characteristics=patient id: 5; tis [Correction source preview truncated.]
Eligible for Patient tissue tumor-vs-normal as Not suitable
dataset_accession: GSE123762 dataset_title: The Androgen Receptor is a Tumor Suppressor in Estrogen Receptor Positive Breast Cancer [Normal and tumor patient-derived explant RNA-seq] organism: Homo sapiens assay_type: bulk RNA-seq sample_context: GSM3510975: source_name=ER+ invasive breast cancer_E2; characteristics=patient id: 1; tissue type: ER+ invasive breast cancer; treatment: E2 GSM3510976: source_name=ER+ invasive breast cancer_E2; characteristics=patient id: 2; tissue type: ER+ invasive breast cancer; treatment: E2 GSM3510977: source_name=ER+ invasive breast cancer_E2; characteristics=patient id: 3; tissue type: ER+ invasive breast cancer; treatment: E2 GSM3510978: source_name=ER+ invasive breast cancer_E2; characteristics=patient id: 4; tissue type: ER+ invasive breast cancer; treatment: E2 GSM3510979: source_name=ER+ invasive breast cancer_E2; characteristics=patient id: 5; tis [Correction source preview truncated.]
breast cancer (case)
sample_accession: GSM3510975 sample_title: TH1-E source_name: ER+ invasive breast cancer_E2 characteristics: patient id: 1; tissue type: ER+ invasive breast cancer; treatment: E2
Included in derived sample grouping as breast cancer
sample_accession: GSM3510975 sample_title: TH1-E source_name: ER+ invasive breast cancer_E2 characteristics: patient id: 1; tissue type: ER+ invasive breast cancer; treatment: E2
breast cancer (case)
sample_accession: GSM3510976 sample_title: TH2-E source_name: ER+ invasive breast cancer_E2 characteristics: patient id: 2; tissue type: ER+ invasive breast cancer; treatment: E2
Included in derived sample grouping as breast cancer
sample_accession: GSM3510976 sample_title: TH2-E source_name: ER+ invasive breast cancer_E2 characteristics: patient id: 2; tissue type: ER+ invasive breast cancer; treatment: E2
breast cancer (case)
sample_accession: GSM3510977 sample_title: TH3-E source_name: ER+ invasive breast cancer_E2 characteristics: patient id: 3; tissue type: ER+ invasive breast cancer; treatment: E2
Included in derived sample grouping as breast cancer
sample_accession: GSM3510977 sample_title: TH3-E source_name: ER+ invasive breast cancer_E2 characteristics: patient id: 3; tissue type: ER+ invasive breast cancer; treatment: E2
breast cancer (case)
sample_accession: GSM3510978 sample_title: TH4-E source_name: ER+ invasive breast cancer_E2 characteristics: patient id: 4; tissue type: ER+ invasive breast cancer; treatment: E2
Included in derived sample grouping as breast cancer
sample_accession: GSM3510978 sample_title: TH4-E source_name: ER+ invasive breast cancer_E2 characteristics: patient id: 4; tissue type: ER+ invasive breast cancer; treatment: E2
breast cancer (case)
sample_accession: GSM3510979 sample_title: TH5-E source_name: ER+ invasive breast cancer_E2 characteristics: patient id: 5; tissue type: ER+ invasive breast cancer; treatment: E2
Included in derived sample grouping as breast cancer
sample_accession: GSM3510979 sample_title: TH5-E source_name: ER+ invasive breast cancer_E2 characteristics: patient id: 5; tissue type: ER+ invasive breast cancer; treatment: E2
breast cancer (case)
sample_accession: GSM3510980 sample_title: TH6-E source_name: ER+ invasive breast cancer_E2 characteristics: patient id: 6; tissue type: ER+ invasive breast cancer; treatment: E2
Included in derived sample grouping as breast cancer
sample_accession: GSM3510980 sample_title: TH6-E source_name: ER+ invasive breast cancer_E2 characteristics: patient id: 6; tissue type: ER+ invasive breast cancer; treatment: E2
breast cancer (case)
sample_accession: GSM3510981 sample_title: TH7-E source_name: ER+ invasive breast cancer_E2 characteristics: patient id: 7; tissue type: ER+ invasive breast cancer; treatment: E2
Included in derived sample grouping as breast cancer
sample_accession: GSM3510981 sample_title: TH7-E source_name: ER+ invasive breast cancer_E2 characteristics: patient id: 7; tissue type: ER+ invasive breast cancer; treatment: E2
breast cancer (case)
sample_accession: GSM3510982 sample_title: TH8-E source_name: ER+ invasive breast cancer_E2 characteristics: patient id: 8; tissue type: ER+ invasive breast cancer; treatment: E2
Included in derived sample grouping as breast cancer
sample_accession: GSM3510982 sample_title: TH8-E source_name: ER+ invasive breast cancer_E2 characteristics: patient id: 8; tissue type: ER+ invasive breast cancer; treatment: E2
breast cancer (case)
sample_accession: GSM3510983 sample_title: TH1-ED source_name: ER+ invasive breast cancer_E2+DHT characteristics: patient id: 1; tissue type: ER+ invasive breast cancer; treatment: E2+DHT
Included in derived sample grouping as breast cancer
sample_accession: GSM3510983 sample_title: TH1-ED source_name: ER+ invasive breast cancer_E2+DHT characteristics: patient id: 1; tissue type: ER+ invasive breast cancer; treatment: E2+DHT
breast cancer (case)
sample_accession: GSM3510984 sample_title: TH2-ED source_name: ER+ invasive breast cancer_E2+DHT characteristics: patient id: 2; tissue type: ER+ invasive breast cancer; treatment: E2+DHT
Included in derived sample grouping as breast cancer
sample_accession: GSM3510984 sample_title: TH2-ED source_name: ER+ invasive breast cancer_E2+DHT characteristics: patient id: 2; tissue type: ER+ invasive breast cancer; treatment: E2+DHT
breast cancer (case)
sample_accession: GSM3510985 sample_title: TH3-ED source_name: ER+ invasive breast cancer_E2+DHT characteristics: patient id: 3; tissue type: ER+ invasive breast cancer; treatment: E2+DHT
Included in derived sample grouping as breast cancer
sample_accession: GSM3510985 sample_title: TH3-ED source_name: ER+ invasive breast cancer_E2+DHT characteristics: patient id: 3; tissue type: ER+ invasive breast cancer; treatment: E2+DHT
breast cancer (case)
sample_accession: GSM3510986 sample_title: TH4-ED source_name: ER+ invasive breast cancer_E2+DHT characteristics: patient id: 4; tissue type: ER+ invasive breast cancer; treatment: E2+DHT
Included in derived sample grouping as breast cancer
sample_accession: GSM3510986 sample_title: TH4-ED source_name: ER+ invasive breast cancer_E2+DHT characteristics: patient id: 4; tissue type: ER+ invasive breast cancer; treatment: E2+DHT
breast cancer (case)
sample_accession: GSM3510987 sample_title: TH5-ED source_name: ER+ invasive breast cancer_E2+DHT characteristics: patient id: 5; tissue type: ER+ invasive breast cancer; treatment: E2+DHT
Included in derived sample grouping as breast cancer
sample_accession: GSM3510987 sample_title: TH5-ED source_name: ER+ invasive breast cancer_E2+DHT characteristics: patient id: 5; tissue type: ER+ invasive breast cancer; treatment: E2+DHT
breast cancer (case)
sample_accession: GSM3510988 sample_title: TH6-ED source_name: ER+ invasive breast cancer_E2+DHT characteristics: patient id: 6; tissue type: ER+ invasive breast cancer; treatment: E2+DHT
Included in derived sample grouping as breast cancer
sample_accession: GSM3510988 sample_title: TH6-ED source_name: ER+ invasive breast cancer_E2+DHT characteristics: patient id: 6; tissue type: ER+ invasive breast cancer; treatment: E2+DHT
breast cancer (case)
sample_accession: GSM3510989 sample_title: TH7-ED source_name: ER+ invasive breast cancer_E2+DHT characteristics: patient id: 7; tissue type: ER+ invasive breast cancer; treatment: E2+DHT
Included in derived sample grouping as breast cancer
sample_accession: GSM3510989 sample_title: TH7-ED source_name: ER+ invasive breast cancer_E2+DHT characteristics: patient id: 7; tissue type: ER+ invasive breast cancer; treatment: E2+DHT
breast cancer (case)
sample_accession: GSM3510990 sample_title: TH8-ED source_name: ER+ invasive breast cancer_E2+DHT characteristics: patient id: 8; tissue type: ER+ invasive breast cancer; treatment: E2+DHT
Included in derived sample grouping as breast cancer
sample_accession: GSM3510990 sample_title: TH8-ED source_name: ER+ invasive breast cancer_E2+DHT characteristics: patient id: 8; tissue type: ER+ invasive breast cancer; treatment: E2+DHT
normal tissue (control)
sample_accession: GSM3510991 sample_title: TH-81 E source_name: Normal breast_E2 characteristics: patient id: 81; tissue type: Normal breast; treatment: E2
Included in derived sample grouping as normal tissue
sample_accession: GSM3510991 sample_title: TH-81 E source_name: Normal breast_E2 characteristics: patient id: 81; tissue type: Normal breast; treatment: E2
normal tissue (control)
sample_accession: GSM3510992 sample_title: TH-82 E source_name: Normal breast_E2 characteristics: patient id: 82; tissue type: Normal breast; treatment: E2
Included in derived sample grouping as normal tissue
sample_accession: GSM3510992 sample_title: TH-82 E source_name: Normal breast_E2 characteristics: patient id: 82; tissue type: Normal breast; treatment: E2
normal tissue (control)
sample_accession: GSM3510993 sample_title: TH-83 E source_name: Normal breast_E2 characteristics: patient id: 83; tissue type: Normal breast; treatment: E2
Included in derived sample grouping as normal tissue
sample_accession: GSM3510993 sample_title: TH-83 E source_name: Normal breast_E2 characteristics: patient id: 83; tissue type: Normal breast; treatment: E2
normal tissue (control)
sample_accession: GSM3510994 sample_title: TH-84 E source_name: Normal breast_E2 characteristics: patient id: 84; tissue type: Normal breast; treatment: E2
Included in derived sample grouping as normal tissue
sample_accession: GSM3510994 sample_title: TH-84 E source_name: Normal breast_E2 characteristics: patient id: 84; tissue type: Normal breast; treatment: E2
normal tissue (control)
sample_accession: GSM3510995 sample_title: TH-85 E source_name: Normal breast_E2 characteristics: patient id: 85; tissue type: Normal breast; treatment: E2
Included in derived sample grouping as normal tissue
sample_accession: GSM3510995 sample_title: TH-85 E source_name: Normal breast_E2 characteristics: patient id: 85; tissue type: Normal breast; treatment: E2
normal tissue (control)
sample_accession: GSM3510996 sample_title: TH-86 E source_name: Normal breast_E2 characteristics: patient id: 86; tissue type: Normal breast; treatment: E2
Included in derived sample grouping as normal tissue
sample_accession: GSM3510996 sample_title: TH-86 E source_name: Normal breast_E2 characteristics: patient id: 86; tissue type: Normal breast; treatment: E2
normal tissue (control)
sample_accession: GSM3510997 sample_title: TH-87 E source_name: Normal breast_E2 characteristics: patient id: 87; tissue type: Normal breast; treatment: E2
Included in derived sample grouping as normal tissue
sample_accession: GSM3510997 sample_title: TH-87 E source_name: Normal breast_E2 characteristics: patient id: 87; tissue type: Normal breast; treatment: E2
normal tissue (control)
sample_accession: GSM3510998 sample_title: TH-88 E source_name: Normal breast_E2 characteristics: patient id: 88; tissue type: Normal breast; treatment: E2
Included in derived sample grouping as normal tissue
sample_accession: GSM3510998 sample_title: TH-88 E source_name: Normal breast_E2 characteristics: patient id: 88; tissue type: Normal breast; treatment: E2
normal tissue (control)
sample_accession: GSM3510999 sample_title: TH-89 E source_name: Normal breast_E2 characteristics: patient id: 89; tissue type: Normal breast; treatment: E2
Included in derived sample grouping as normal tissue
sample_accession: GSM3510999 sample_title: TH-89 E source_name: Normal breast_E2 characteristics: patient id: 89; tissue type: Normal breast; treatment: E2
normal tissue (control)
sample_accession: GSM3511000 sample_title: TH-101 E source_name: Normal breast_E2 characteristics: patient id: 101; tissue type: Normal breast; treatment: E2
Included in derived sample grouping as normal tissue
sample_accession: GSM3511000 sample_title: TH-101 E source_name: Normal breast_E2 characteristics: patient id: 101; tissue type: Normal breast; treatment: E2
normal tissue (control)
sample_accession: GSM3511001 sample_title: TH-102 E source_name: Normal breast_E2 characteristics: patient id: 102; tissue type: Normal breast; treatment: E2
Included in derived sample grouping as normal tissue
sample_accession: GSM3511001 sample_title: TH-102 E source_name: Normal breast_E2 characteristics: patient id: 102; tissue type: Normal breast; treatment: E2
normal tissue (control)
sample_accession: GSM3511002 sample_title: TH-103 E source_name: Normal breast_E2 characteristics: patient id: 103; tissue type: Normal breast; treatment: E2
Included in derived sample grouping as normal tissue
sample_accession: GSM3511002 sample_title: TH-103 E source_name: Normal breast_E2 characteristics: patient id: 103; tissue type: Normal breast; treatment: E2
normal tissue (control)
sample_accession: GSM3511003 sample_title: TH-104 E source_name: Normal breast_E2 characteristics: patient id: 104; tissue type: Normal breast; treatment: E2
Included in derived sample grouping as normal tissue
sample_accession: GSM3511003 sample_title: TH-104 E source_name: Normal breast_E2 characteristics: patient id: 104; tissue type: Normal breast; treatment: E2
normal tissue (control)
sample_accession: GSM3511004 sample_title: TH-105 E source_name: Normal breast_E2 characteristics: patient id: 105; tissue type: Normal breast; treatment: E2
Included in derived sample grouping as normal tissue
sample_accession: GSM3511004 sample_title: TH-105 E source_name: Normal breast_E2 characteristics: patient id: 105; tissue type: Normal breast; treatment: E2
normal tissue (control)
sample_accession: GSM3511005 sample_title: TH-106 E source_name: Normal breast_E2 characteristics: patient id: 106; tissue type: Normal breast; treatment: E2
Included in derived sample grouping as normal tissue
sample_accession: GSM3511005 sample_title: TH-106 E source_name: Normal breast_E2 characteristics: patient id: 106; tissue type: Normal breast; treatment: E2
normal tissue (control)
sample_accession: GSM3511006 sample_title: TH-107 E source_name: Normal breast_E2 characteristics: patient id: 107; tissue type: Normal breast; treatment: E2
Included in derived sample grouping as normal tissue
sample_accession: GSM3511006 sample_title: TH-107 E source_name: Normal breast_E2 characteristics: patient id: 107; tissue type: Normal breast; treatment: E2
normal tissue (control)
sample_accession: GSM3511007 sample_title: TH-108 E source_name: Normal breast_E2 characteristics: patient id: 108; tissue type: Normal breast; treatment: E2
Included in derived sample grouping as normal tissue
sample_accession: GSM3511007 sample_title: TH-108 E source_name: Normal breast_E2 characteristics: patient id: 108; tissue type: Normal breast; treatment: E2
normal tissue (control)
sample_accession: GSM3511008 sample_title: TH-81 ED source_name: Normal breast_E2+DHT characteristics: patient id: 81; tissue type: Normal breast; treatment: E2+DHT
Included in derived sample grouping as normal tissue
sample_accession: GSM3511008 sample_title: TH-81 ED source_name: Normal breast_E2+DHT characteristics: patient id: 81; tissue type: Normal breast; treatment: E2+DHT
normal tissue (control)
sample_accession: GSM3511009 sample_title: TH-82 ED source_name: Normal breast_E2+DHT characteristics: patient id: 82; tissue type: Normal breast; treatment: E2+DHT
Included in derived sample grouping as normal tissue
sample_accession: GSM3511009 sample_title: TH-82 ED source_name: Normal breast_E2+DHT characteristics: patient id: 82; tissue type: Normal breast; treatment: E2+DHT
normal tissue (control)
sample_accession: GSM3511010 sample_title: TH-83 ED source_name: Normal breast_E2+DHT characteristics: patient id: 83; tissue type: Normal breast; treatment: E2+DHT
Included in derived sample grouping as normal tissue
sample_accession: GSM3511010 sample_title: TH-83 ED source_name: Normal breast_E2+DHT characteristics: patient id: 83; tissue type: Normal breast; treatment: E2+DHT
normal tissue (control)
sample_accession: GSM3511011 sample_title: TH-84 ED source_name: Normal breast_E2+DHT characteristics: patient id: 84; tissue type: Normal breast; treatment: E2+DHT
Included in derived sample grouping as normal tissue
sample_accession: GSM3511011 sample_title: TH-84 ED source_name: Normal breast_E2+DHT characteristics: patient id: 84; tissue type: Normal breast; treatment: E2+DHT
normal tissue (control)
sample_accession: GSM3511012 sample_title: TH-85 ED source_name: Normal breast_E2+DHT characteristics: patient id: 85; tissue type: Normal breast; treatment: E2+DHT
Included in derived sample grouping as normal tissue
sample_accession: GSM3511012 sample_title: TH-85 ED source_name: Normal breast_E2+DHT characteristics: patient id: 85; tissue type: Normal breast; treatment: E2+DHT
normal tissue (control)
sample_accession: GSM3511013 sample_title: TH-86 ED source_name: Normal breast_E2+DHT characteristics: patient id: 86; tissue type: Normal breast; treatment: E2+DHT
Included in derived sample grouping as normal tissue
sample_accession: GSM3511013 sample_title: TH-86 ED source_name: Normal breast_E2+DHT characteristics: patient id: 86; tissue type: Normal breast; treatment: E2+DHT
normal tissue (control)
sample_accession: GSM3511014 sample_title: TH-87 ED source_name: Normal breast_E2+DHT characteristics: patient id: 87; tissue type: Normal breast; treatment: E2+DHT
Included in derived sample grouping as normal tissue
sample_accession: GSM3511014 sample_title: TH-87 ED source_name: Normal breast_E2+DHT characteristics: patient id: 87; tissue type: Normal breast; treatment: E2+DHT
normal tissue (control)
sample_accession: GSM3511015 sample_title: TH-88 ED source_name: Normal breast_E2+DHT characteristics: patient id: 88; tissue type: Normal breast; treatment: E2+DHT
Included in derived sample grouping as normal tissue
sample_accession: GSM3511015 sample_title: TH-88 ED source_name: Normal breast_E2+DHT characteristics: patient id: 88; tissue type: Normal breast; treatment: E2+DHT
normal tissue (control)
sample_accession: GSM3511016 sample_title: TH-89 ED source_name: Normal breast_E2+DHT characteristics: patient id: 89; tissue type: Normal breast; treatment: E2+DHT
Included in derived sample grouping as normal tissue
sample_accession: GSM3511016 sample_title: TH-89 ED source_name: Normal breast_E2+DHT characteristics: patient id: 89; tissue type: Normal breast; treatment: E2+DHT
normal tissue (control)
sample_accession: GSM3511017 sample_title: TH-101 ED source_name: Normal breast_E2+DHT characteristics: patient id: 101; tissue type: Normal breast; treatment: E2+DHT
Included in derived sample grouping as normal tissue
sample_accession: GSM3511017 sample_title: TH-101 ED source_name: Normal breast_E2+DHT characteristics: patient id: 101; tissue type: Normal breast; treatment: E2+DHT
normal tissue (control)
sample_accession: GSM3511018 sample_title: TH-102 ED source_name: Normal breast_E2+DHT characteristics: patient id: 102; tissue type: Normal breast; treatment: E2+DHT
Included in derived sample grouping as normal tissue
sample_accession: GSM3511018 sample_title: TH-102 ED source_name: Normal breast_E2+DHT characteristics: patient id: 102; tissue type: Normal breast; treatment: E2+DHT
normal tissue (control)
sample_accession: GSM3511019 sample_title: TH-103 ED source_name: Normal breast_E2+DHT characteristics: patient id: 103; tissue type: Normal breast; treatment: E2+DHT
Included in derived sample grouping as normal tissue
sample_accession: GSM3511019 sample_title: TH-103 ED source_name: Normal breast_E2+DHT characteristics: patient id: 103; tissue type: Normal breast; treatment: E2+DHT
normal tissue (control)
sample_accession: GSM3511020 sample_title: TH-104 ED source_name: Normal breast_E2+DHT characteristics: patient id: 104; tissue type: Normal breast; treatment: E2+DHT
Included in derived sample grouping as normal tissue
sample_accession: GSM3511020 sample_title: TH-104 ED source_name: Normal breast_E2+DHT characteristics: patient id: 104; tissue type: Normal breast; treatment: E2+DHT
normal tissue (control)
sample_accession: GSM3511021 sample_title: TH-105 ED source_name: Normal breast_E2+DHT characteristics: patient id: 105; tissue type: Normal breast; treatment: E2+DHT
Included in derived sample grouping as normal tissue
sample_accession: GSM3511021 sample_title: TH-105 ED source_name: Normal breast_E2+DHT characteristics: patient id: 105; tissue type: Normal breast; treatment: E2+DHT
normal tissue (control)
sample_accession: GSM3511022 sample_title: TH-106 ED source_name: Normal breast_E2+DHT characteristics: patient id: 106; tissue type: Normal breast; treatment: E2+DHT
Included in derived sample grouping as normal tissue
sample_accession: GSM3511022 sample_title: TH-106 ED source_name: Normal breast_E2+DHT characteristics: patient id: 106; tissue type: Normal breast; treatment: E2+DHT
normal tissue (control)
sample_accession: GSM3511023 sample_title: TH-107 ED source_name: Normal breast_E2+DHT characteristics: patient id: 107; tissue type: Normal breast; treatment: E2+DHT
Included in derived sample grouping as normal tissue
sample_accession: GSM3511023 sample_title: TH-107 ED source_name: Normal breast_E2+DHT characteristics: patient id: 107; tissue type: Normal breast; treatment: E2+DHT
normal tissue (control)
sample_accession: GSM3511024 sample_title: TH-108 ED source_name: Normal breast_E2+DHT characteristics: patient id: 108; tissue type: Normal breast; treatment: E2+DHT
Included in derived sample grouping as normal tissue
sample_accession: GSM3511024 sample_title: TH-108 ED source_name: Normal breast_E2+DHT characteristics: patient id: 108; tissue type: Normal breast; treatment: E2+DHT
Original dataset metadata, sample metadata, source links, and GEO data availability flags.
Planned trusted source for processed count availability.
Planned source for curated expression experiment links.
Publication context when PubMed identifiers are already known.
No project feedback stored for this dataset.
dataset_accession: GSE123762 dataset_title: The Androgen Receptor is a Tumor Suppressor in Estrogen Receptor Positive Breast Cancer [Normal and tumor patient-derived explant RNA-seq] organism: Homo sapiens assay_type: bulk RNA-seq processed_data_available: true raw_data_available: true submission_date: 2018-12-13 last_update_date: 2021-01-26 organization_name: Flinders University department: College of Medicine and Public Health public_date: 2021-01-18 experiment_types: Expression profiling by high throughput sequencing platforms: GPL16791 Illumina HiSeq 2500 (Homo sapiens) sub_series: Not available bioproject: PRJNA509777 supplementary_files: XLSX: GSE123762_Invasive_breast_cancer_E_v_ED_normalised_expression_RPKM.xlsx; XLSX: GSE123762_Normal_breast_E_v_ED_combined_expression_RPKM.xlsx series_type: SubSeries
No warnings
Samples currently treated as the comparison case group.
Samples currently treated as controls or baseline.
Samples with no explicit case or control marker.
No samples
Samples excluded from grouping by hard exclusion rules.
No samples
Samples that need manual review before trusting grouping.
No samples
No review decisions have been stored for this dataset.